OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

An mpox virus mRNA-lipid nanoparticle vaccine confers protection against lethal orthopoxviral challenge
Alec W. Freyn, Caroline Atyeo, Patricia L. Earl, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 716
Closed Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

A multivalent mRNA monkeypox virus vaccine (BNT166) protects mice and macaques from orthopoxvirus disease
Adam Zuiani, Charles L. Dulberger, Nilushi S. De Silva, et al.
Cell (2024) Vol. 187, Iss. 6, pp. 1363-1373.e12
Open Access | Times Cited: 59

Understanding the biology of monkeypox virus to prevent future outbreaks
Bernard Moss
Nature Microbiology (2024) Vol. 9, Iss. 6, pp. 1408-1416
Closed Access | Times Cited: 22

Comparison of protection against mpox following mRNA or modified vaccinia Ankara vaccination in nonhuman primates
Eric M. Mucker, Alec W. Freyn, Sandra L. Bixler, et al.
Cell (2024) Vol. 187, Iss. 20, pp. 5540-5553.e10
Open Access | Times Cited: 19

Rational design of a ‘two-in-one’ immunogen DAM drives potent immune response against mpox virus
Han Wang, Peng Yin, Tingting Zheng, et al.
Nature Immunology (2024) Vol. 25, Iss. 2, pp. 307-315
Closed Access | Times Cited: 16

The monkeypox virus-host interplays
Xuemei Yi, Yali Lei, Mi Li, et al.
Cell Insight (2024) Vol. 3, Iss. 5, pp. 100185-100185
Open Access | Times Cited: 13

Current advances and challenges in mpox vaccine development: a global landscape
Maryam Shafaati, Shayan Forghani, Amirhossein Shahsavand Davoudi, et al.
Therapeutic Advances in Vaccines and Immunotherapy (2025) Vol. 13
Open Access | Times Cited: 1

mRNA vaccines for infectious diseases — advances, challenges and opportunities
Norbert Pardi, Florian Krammer
Nature Reviews Drug Discovery (2024)
Closed Access | Times Cited: 10

Longitudinal viral shedding and antibody response characteristics of men with acute infection of monkeypox virus: a prospective cohort study
Yang Yang, Shiyu Niu, Chenguang Shen, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 9

Comparison of the immunogenicity and protective efficacy of ACAM2000, MVA, and vectored subunit vaccines for Mpox in rhesus macaques
Catherine Jacob-Dolan, Darren Ty, David Hope, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 740
Closed Access | Times Cited: 8

Polyvalent mpox mRNA vaccines elicit robust immune responses and confer potent protection against vaccinia virus
Tianxi Ye, Jinge Zhou, Chen Guo, et al.
Cell Reports (2024) Vol. 43, Iss. 6, pp. 114269-114269
Open Access | Times Cited: 7

Advanced technologies for the development of infectious disease vaccines
Akash Gupta, Arnab Rudra, Kaelan Reed, et al.
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 12, pp. 914-938
Closed Access | Times Cited: 7

RETRACTED ARTICLE: An overview on mRNA-based vaccines to prevent monkeypox infection
Mohammad Natami, Amirsasan Gorgzadeh, Arsalan Gholipour, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5

Enhanced Immunogenicity and Affinity with A35R-Fc-Based Chimeric Protein Compared to MPXV A35R Protein
Shimeng Bai, Yanxin Cui, Qibin Liao, et al.
Viruses (2025) Vol. 17, Iss. 1, pp. 116-116
Open Access

Assessment of MpoxPlex, a high-throughput and multiplexed immunoassay: a diagnostic accuracy study
Scott Jones, Bethany Hicks, Helen Callaby, et al.
The Lancet Microbe (2025), pp. 100987-100987
Open Access

Immunobiology of MPox Infection and Its Management: Experience From Developing Nations
Om Saswat Sahoo, Daina Sapam, Swati Ajmeria, et al.
Reviews in Medical Virology (2025) Vol. 35, Iss. 1
Closed Access

Elucidating the Mechanism of VVTT Infection Through Machine Learning and Transcriptome Analysis
Zhili Chen, Yongxin Jiang, Jiazhen Cui, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1203-1203
Open Access

现代疫苗学赋能新突发病毒性传染病疫苗的快速“智造”——以猴痘疫情为例
Tingting Zheng, Han Wang, Qihui Wang
Chinese Science Bulletin (Chinese Version) (2025) Vol. 70, Iss. 7, pp. 789-798
Closed Access

Structural insights into tecovirimat antiviral activity and poxvirus resistance
Riccardo Vernuccio, Alejandro Martínez León, Chetan Poojari, et al.
Nature Microbiology (2025) Vol. 10, Iss. 3, pp. 734-748
Open Access

Inhibition of Polo‐Like Kinase 1 Dampens the Replication of Vaccinia Virus in Mammalian Cells
Junda Zhu, Xudong Jia, Shuning Ren, et al.
Journal of Medical Virology (2025) Vol. 97, Iss. 2
Closed Access

Lessons for Medical Countermeasure Development from Unforeseen Outbreaks
Marie Mura, Aurélie Trignol, E. Le Dault, et al.
Emerging Microbes & Infections (2025)
Open Access

Human antibody responses to circulating monkeypox virus emphasise the need for the first mpox-specific vaccine
Raianna F. Fantin, Camila H. Coelho
The Lancet Microbe (2024) Vol. 5, Iss. 3, pp. e204-e205
Open Access | Times Cited: 4

Rapid development of double-hit mRNA antibody cocktail against orthopoxviruses
Hang Chi, Suo-Qun Zhao, Ru-Yi Chen, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 4

MVA-BN Vaccine Effectiveness: A Systematic Review of Real-World Evidence in Outbreak Settings
Lauren M.K. Mason, Estefania Betancur, Margarita Riera-Montes, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 4

Page 1 - Next Page

Scroll to top